South African scientists were testing a promising HIV vaccine. Then came Trump's aid cuts
JOHANNESBURG, Feb 18 (Reuters) - South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order came from USAID to stop work.
The first round of vaccines she and her colleagues made in Johannesburg had produced an immune response in rabbits, which was promising but not conclusive - so they tweaked the formula and sent off four new versions for pre-clinical tests.
"This was very exciting. We were getting quite good results," Mlotshwa, 32, told Reuters in the lab in the Antiviral Gene Therapy Research Unit at the city's University of the Witwatersrand.
Now the animal blood samples containing their results are sitting untouched in a freezer.
A trial of an earlier, separate vaccine candidate, which was about to be tested on humans in South Africa as well as Kenya and Uganda, is also on ice.
Both trials are among the casualties of U.S. President Donald Trump's decision to dismantle the United States Agency for International Development (USAID).
They are part of a wider South African-led HIV vaccine development scheme known as BRILLIANT and funded entirely by a $45 million grant from USAID. It is unclear if or when the project could resume. The U.S. State Department did not immediately respond to a request for comment.
"It feels like you're building something and you could really make a huge difference," Nigel Garrett, Chief Scientific Officer at the Desmond Tutu Health Foundation, a partner in the project, said.
"And then it's wiped away."
The project is one of many research efforts worldwide to be hit by Trump's actions since taking office last month. Others include halting efforts to protect food crops from pests and diseases and blocking publication of a paper on the mpox outbreak.
'HOLY GRAIL'
HIV's ability to mutate quickly has confounded efforts to create a vaccine ever since it was first identified in 1983. The researchers in Johannesburg are using the mRNA technology that created some COVID-19 vaccines.
Several other mRNA-based HIV vaccine candidates worldwide have reached clinical trials. BRILLIANT is unique in being Africa-led, aiming to develop capacity for producing vaccines in Africa.
For the past year the Johannesburg team had been working with genetic sequences from two South African patients who have HIV but whose bodies produce a rare type of antibody that neutralizes the virus. They are trying to simulate that immune response.
"We were gaining momentum," said Patrick Arbuthnot, director of the research unit, adding: "an HIV vaccine is the holy grail of the field".
Trump in January ordered a 90-day pause in all foreign development assistance pending assessment of its consistency with his "America First" foreign policy.
Separately, he has targeted South Africa with an executive order to cut all funding to the country, citing disapproval of its land reform policy and its genocide case against U.S. ally Israel.
The U.S. foreign aid freeze has affected programmes across the globe, stranding shipments of life-saving medical supplies, including HIV drugs, and leaving disaster response teams unable to deploy. Waivers for "life-saving humanitarian assistance" have been hampered.
'GOOD FOR THE WORLD'
Because South Africa has the world's largest population of people living with HIV, at more than 8 million, it is a hub for research on the virus.
"Most of the landmark and groundbreaking studies have been conducted in this country. But these have been good for the whole world," said Ntobeko Ntusi, CEO of the South African Medical Research Council, which is spearheading the HIV vaccine search.
Ntusi said he did not expect funding for projects like BRILLIANT to resume, given the executive order on aid to South Africa. The council gets about a third of its funding from U.S. federal sources, for research that is mostly on HIV and tuberculosis but covers other areas including maternal and infant mortality and antimicrobial resistance, he said.
Garrett said the shot that was ready for testing on humans was a mix of two vaccine substances developed in the United States and the Netherlands which have shown promise but never been tested together.
They are now sitting in storage.
"We had a huge opportunity, good funding. It's difficult for other funders to fill that gap," he said.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
2 hours ago
- Daily Mirror
NHS could issue first ever 'Red Alert' for blood donations as stocks run low
NHS says transfusions for cancer patients and women after childbirth are among those which may be halted if a Red Alert is declared for the first time ever as the service struggles with low stocks A million people need to give blood to avoid a first ever Red Alert as the NHS struggles with dangerously low stocks. NHS Blood and Transplant says it is going through its worst ever shortage and around 200,000 more donors are needed in England to stabilise blood supply. Routine transfusions for cancer patients and women after childbirth which aid recovery are among those which may be halted if a Red Alert is declared. This would mean less than one day's blood stocks are available and must be prioritised for immediately life threatening cases. The NHS aims to have six days' stock at any one time. Currently 785,000 people - or 2% of the population - are keeping the nation's blood stocks afloat. The NHS is asking more people to give blood regularly and tackle the crisis with 'the country's largest volunteering force'. Health Minister Baroness Merron said: 'I am extremely grateful to the many thousands of people who donate regularly – the blood you donate saves people's lives, from mothers in maternity wards to victims of car crashes. However the NHS is in urgent need of more lifesaving blood donors from all backgrounds.' It comes after the Mirror launched the Give a Pint, Save a Life campaign to help blood stocks recover after the Covid-19 pandemic amid ongoing shortages. One donation can save up to three lives. The NHS remains in its longest ever Amber Alert for low blood stocks which was declared last July. Red Alert which would mean demand far exceeds capacity, threatening public safety and causing widespread surgery postponements at hospitals nationwide. The shortages are due in part to changing habits as more people work from home since the Covid-19 pandemic. Most available donation slots are at larger town and city centres. NHSBT chief executive Dr Jo Farrar said: 'There are many thousands of people who donate regularly and help us keep patients alive. You keep the NHS going and save and transform thousands of lives a year. Our stocks over the past 12 months have been challenging. If we had a million regular donors, this would help keep our stocks healthy – you'd truly be one in a million." Isaac and his 'Hulk blood' The NHS is calling for a million donor superheroes to start giving blood to help keep people like Hulk fan Isaac Balmer alive. Isaac, aged four, needs his regular supply of 'Hulk blood' every 12 weeks to keep him strong and healthy. The youngster from Hull was born with Hereditary Spherocytosis, which is a genetic blood condition which causes fragile red blood cells to break down faster than normal leading to severe anaemia and other complications. Mum Jasmin Suggit said: "During his transfusions, he refers to donor blood as 'Hulk blood' and imagines himself becoming stronger and healthier. She said: 'Isaac's haemoglobin levels fluctuate and when they drop significantly, he becomes lethargic and jaundiced. But when he receives his transfusion you see the colour return to his cheeks and his energy levels soar before our eyes. It is incredible. But this wouldn't be possible without the real life, everyday superheroes who keep Isaac and others like him alive, thanks to their regular blood donations.' Two thirds of all the blood currently collected by the NHS is used to treat patients who rely on blood transfusions, including cancer and life-long blood conditions. Isaac receives transfusions every three months at Hull Royal Infirmary where mum Jasmin works in the newborn screening team. Jasmin said: "Until you're one of those who need blood yourself or know someone who does, it may not always be a priority. But Isaac's journey has put things into perspective and his journey has inspired me to become a blood donor myself. It's a small act that can make a big difference in someone's life." There are currently between two and three days' of blood stocks available to the NHS but rates of donations have been falling. There are 55,000 unfilled appointment slots in the next six weeks. The 'active donor base' - which refers to donors who have given blood in the last 12 months - stood at 785,000 at last count in April. This is down from 800,000 before the pandemic in 2020. The NHS needs over 5,000 blood donations every day - or around 1.8 million a year in England. This requires around one million donors who regularly donate to help maintain a reliable blood supply. NHSBT's blood director Gerry Gogarty said: 'Blood stocks are critically low and there's a pressing need to avoid a Red Alert. We can do this if we fill the available appointment slots – particularly in town and city centres. That could have a severe impact on the NHS with non-urgent services potentially being paused to focus on the most critical needs.' There is a critical need for O negative donors – the universal blood type compatible with anyone and used in emergencies. Just 8% of the population have O negative blood but it accounts for 15% of the blood used by hospitals and first responders. There is also an increasing need for donors of Black heritage as around 50% have a blood subtype called Ro, which is used primarily to treat people with sickle cell disease. This is the country's fastest growing genetic blood disorder and patients require regular transfusions to prevent agonising and life threatening blockages. Last year England saw an increased wave of blood donation registrations – including the largest ever increase in registrations from Black heritage communities. However only one in four have gone on to donate, with a quarter of a million people who signed up yet to roll up their sleeves to make a lifesaving donation. Professor Meghana Pandit, NHS Co-National Medical Director, said: 'Regular blood donors provide a lifeline for patients across the NHS, and I'd like to thank them for their incredible generosity. Donating blood is a powerful way you can make a meaningful difference to people's lives, so I'd encourage anyone considering becoming a donor to please come forward to help stabilise blood stocks as we near a critical low – you could help save someone's life.' What would a Red Alert mean? The Red Alert has never before been used but is designed to help the NHS save and improve as many lives as possible. Routine procedures which require blood will be postponed so stocks are preserved for patients with life threatening haemorrhages, emergency operations such as heart surgery which cannot be delayed for 24 hours and patients who need a lifesaving transfusion due to illness. NHS Blood and Transplant will declare a Red Alert for blood stocks if there is a severe shortage of red cells. There are two levels of Red alert, dependent on the number of days of stock available. 'Red B' is between 0.5 and 1.0 days' supply of stock; 'Red A' is less than 0.5 days' supply of stock. The appeal comes just before the one year anniversary of the Amber Alert being in place across England and at the start of National Blood Week. NHSBT chief executive Dr Jo Farrar added: "Please book an appointment today, experience how good it feels to save lives, and come and do it again in a few months.'
North Wales Live
3 hours ago
- North Wales Live
8ft ambush shark 'more common' than thought on Welsh coast
An enigmatic species of shark known to be favour Welsh waters could be more abundant than previous suspected, scientists believe. The Angel shark, a large flat species resembling a stingray, is unique because it has evolved very differently to other types of shark. Previously only reliably spotted around the Canary Islands, catch evidence from Welsh fishermen has shown that Cardigan Bay is also a stronghold for this elusive and vulnerable species. The Welsh population had thought to be shrinking dramatically as a result of habitat damage and bycatch fishing, with one study indicating a 70% decline since 1970. A major conservation project was launched in the hope of saving a species that lingers on the sea floor, half-buried in sand and mud, waiting for prey to swim near them. They can grow up to 2.4m (8ft) long. However a new study, 'People & Nature', from the Zoological Society of London (ZSL) and Natural Resources Wales (NRW) suggests previous Angel shark counts were wide of the mark. Its authors believes changes to commercial fishing practices have seen fewer angel sharks caught. As the speckled, caramel-coloured sharks are masters of camouflage, finding them on the sea floor is virtually impossible. Instead, evidence from boat captains is the only reliable way the population can be assessed. It's now thought fishermen are catching fewer not because numbers are dwindling but because they are targeting different waters and using species-specific nets. To reach its conclusions, the ZSL-led study harnessed the expertise of Welsh fishing organisations. Co-author was Charlie Bartlett, a charter fisherman from Gwynedd, who said: 'I've spent over 50 years working along the Welsh coast, and over the years I've come to know these waters inside out. 'With their large, flat fins, Angel sharks are unlike any other shark we see here - and over the years I've been fortunate to encounter the species a number of times.' In the 40 years to 2020, some 1,642 Angel sharks were reported in Welsh coastal waters. A particular safe haven is in an area south of the Llŷn Peninsula. While they pose very little risk to humans, they have been known to bite when provoked. Literature analysis going back two centuries revealed they have a long maritime heritage in Wales. No fewer than 16 different names were uncovered, including Monkfish, Banjofish, Bafoon, Shovelnose and Devilfish. Its traditional Welsh name is Maelgi (Monkfish). The species has been adopted as the flagship species for marine conservation in Wales. Working with the Welsh Fishermen's Association (Cymdeithas Pysgotwyr) and Angling Cymru Sea Anglers, scientists interviewed 27 fishers about their operations between 1968 and 2019. It became clear modern practices involve fewer interactions with Angel sharks, leading to fewer sightings. Lead author Francesca Mason, a ZSL researcher at the Institute of Zoology's Ocean Predator Lab, said: 'There may be more Angel sharks swimming off the Welsh coast than we previously thought – we're just having a harder time spotting them. 'While this is a good sign if less Angel sharks are being caught accidentally, it also means we now need new ways to monitor them to build a more accurate picture of how these sharks are doing.' Instead of relying on chance sightings, scientists are now pinning their hopes on a novel technique involving environmental DNA (eDNA). This can build up in the shark's surroundings through the shedding of dead skin cells or blood loss from a wound. Already eDNA is being measured for Angel Shark Project: Wales, part of the wider work of Project SIARC (Sharks Inspiring Action and Research with Communities). Jake Davies, technical specialist for Project SIARC, said: 'With their excellent camouflage, one of the hardest challenges we face studying Angel sharks is simply finding them. eDNA allows us to study species without having to spot them. 'By studying eDNA in Cardigan and Carmarthen Bays, we've confirmed the presence of a range of native sharks, skates and rays - including Angel sharks - in these more turbulent waters where other monitoring methods aren't as effective. 'Fishers today may be less likely to come across Angel sharks than they were 50 years ago, but through combining this technique with local knowledge, we can continue building a stronger picture of their status and distribution along the Welsh coast.' The Angel shark work was supported by the On the Edge conservation charity, the National Lottery Heritage Fund, Welsh Government and the Welsh Government's Nature Networks Fund.
Metro
4 hours ago
- Metro
Nurse struck off after sharing Covid-19 conspiracy theories online
A midwife has been struck off after a string of social media posts spreading conspiracy theories about Covid-19 and vaccinations. Seana Mary Kerr, of Newry, Northern Ireland, claimed vaccines attacked babies in the womb. The nurse also warned a pregnant woman not to wear a face mask as it would harm her child. A Nursing and Midwifery Council (NMC) tribunal panel ordered Kerr, who had been a registered midwife since 2007, to be struck off the register because her comments 'risked seriously undermining the public confidence'. All of the incidents took place while she was employed as a registered midwife by Southern Health and Social Care Trust. The midwife first took to social media in September 2020, six months after the first national lockdown due to coronavirus in March. She posted that she was a midwife and said babies were being attacked in the womb through vaccination of mothers during pregnancy. A few months later, in March 2021, she called Covid-19 pandemic 'a Trojan horse intend[ed] to introduce a new era for humanity'. Kerr slammed fellow nurses and doctors as 'complicit' in the conspiracy. In December that year she described how 'they' had been 'planting the seeds' about Covid-19 over Christmas 2020 by referring to 'some bat in China'. She did not specify who 'they' referred to. The panel slammed Kerr for the social media posts. They said: 'The panel considered that the actions of Ms Kerr took place during an exceptionally unusual time, where the entirety of the NHS was mobilised to protect the public from the international Covid-19 pandemic. 'Therefore, by expressing the view that other healthcare professionals, who Ms Kerr was working with in the Trust, were acting in ways which may cause harm, a view Ms Kerr held which was against the recognised guidance at the time, Ms Kerr risked seriously undermining the public confidence in the profession.' The panel also investigated an encounter between the nurse and a pregnant women working in a shop in August 2020. Kerr approached the mum-to-be, explaining she was a nurse and telling her not to wear a face mask. The midwife said face masks reduced the amount of oxygen her baby was getting. Kerr then went on to warn the pregnant women not to get the flu vaccine, saying this raised the risk her child would be stillborn. This was in direct contrast with the Trust's Coronavirus (Covid-19) Infection in Pregnancy policy. This policy advised the wearing of face masks and said the 'influenza vaccination is still safe' and 'recommended' for pregnant women. Kerr's comments caused 'significant emotional harm' to the expecting mum and her family, the panel said. They added: 'The panel noted that it is a reasonable expectation of everyone working in a public environment, such as a shop, that they will not be approached and given personal, clinical advice. 'Such advice would normally only be given during a private clinical appointment or at an antenatal class. More Trending 'Therefore, by approaching Patient A in her place of work, outside a clinical relationship, unsolicited, Ms Kerr placed her at significant risk of harm.' Kerr was found to be at risk of repeating this behaviour and not suitable to continue practice. The nurse showed no remorse for her misconduct had not engaged with the tribunal since June 2022, the panel added. A 12 month suspension was imposed on Kerr last year and her name will now be removed from the register. Get in touch with our news team by emailing us at webnews@ For more stories like this, check our news page. MORE: Urgent recall of 1,700,000 air conditioners over fears they harbour mold MORE: Coca-Cola recalls Topo Chico mineral water over fears of bacteria MORE: Measles warning issued to UK holidaymakers after cases rise over 120,000 in Europe
